What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His scientific interests lie mostly in Immunology, Internal medicine, Beta 2-Glycoprotein I, Antibody and Antiphospholipid syndrome.
Immunology and Single-nucleotide polymorphism are frequently intertwined in his study.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
The study incorporates disciplines such as Molecular biology, Plasma protein binding, Biochemistry and Immunoglobulin G in addition to Beta 2-Glycoprotein I.
His Antibody research integrates issues from Beta and Antigen.
His biological study deals with issues like Lupus anticoagulant, which deal with fields such as Catastrophic antiphospholipid syndrome, Anti-cardiolipin antibodies, Risk factor and Odds ratio.
His most cited work include:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). (4564 citations)
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. (2282 citations)
- Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. (500 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Immunology, Antibody, Rheumatoid arthritis and Antiphospholipid syndrome.
His Internal medicine research incorporates themes from Gastroenterology, Endocrinology and Surgery.
His Immunology study frequently draws connections between adjacent fields such as Transplantation.
Takao Koike has included themes like Postmarketing surveillance, Adverse effect, Infliximab and Arthritis in his Rheumatoid arthritis study.
His Antiphospholipid syndrome research is multidisciplinary, incorporating elements of Lupus anticoagulant and Platelet.
The various areas that Takao Koike examines in his Beta 2-Glycoprotein I study include Molecular biology and Biochemistry.
He most often published in these fields:
- Internal medicine (40.82%)
- Immunology (35.54%)
- Antibody (17.86%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (40.82%)
- Rheumatoid arthritis (15.14%)
- Surgery (10.20%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Rheumatoid arthritis, Surgery, Methotrexate and Gastroenterology.
Within one scientific family, Takao Koike focuses on topics pertaining to Placebo under Internal medicine, and may sometimes address concerns connected to Pharmacokinetics and Dosing.
Many of his research projects under Rheumatoid arthritis are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His Surgery study incorporates themes from Cerebral infarction, Severity of illness and Bacterial pneumonia.
His work in Rheumatology addresses subjects such as Immunology, which are connected to disciplines such as Cancer research.
His Lupus anticoagulant study is concerned with the larger field of Antibody.
Between 2012 and 2021, his most popular works were:
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan (120 citations)
- The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (64 citations)
- The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Takao Koike mainly investigates Internal medicine, Rheumatoid arthritis, Surgery, Gastroenterology and Placebo.
Takao Koike performs integrative Internal medicine and In patient research in his work.
His studies deal with areas such as Postmarketing surveillance, Clinical trial, Vascularity and Abatacept as well as Rheumatoid arthritis.
The concepts of his Surgery study are interwoven with issues in Severity of illness and Arthritis.
His Gastroenterology study combines topics in areas such as Pharmacokinetics and Rheumatoid factor.
His work investigates the relationship between Rheumatology and topics such as Immunology that intersect with problems in Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
